Realtime | Geld | Brief | Zeit |
---|---|---|---|
1,056 | 1,102 | 16:31 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08:30 | Nanoform Finland Oyj: Nanoform Outlicenses Nanoencorafenib And Signs Development And Commercialisation Agreement With A.forall And IMGA | 130 | GlobeNewswire (Europe) | Nanoform Finland Plc | Press Release | October 14, 2025 at 09:30:00 EEST
Helsinki, Finland - Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced that it has... ► Artikel lesen | |
30.09. | Nanoform Finland Oyj: Nanoform Expands Commercial Presence In Asia With A&ls Pharma In South Korea | 479 | GlobeNewswire (Europe) | Nanoform Finland Plc | Press Release | September 30, 2025 at 09:30:00 EEST
Helsinki, Finland - Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced it has entered... ► Artikel lesen | |
21.08. | Nanoform Finland Oyj: Nanoform Q2 2025 report: Continued progress on many fronts, supportive first preliminary pivotal nanoenzalutamide study results | 1.367 | GlobeNewswire (Europe) | Nanoform Finland Plc | Company Release | August 21, 2025 at 08:10:00 EEST
First preliminary pivotal study results supportive for project Nanoenzalutamide to continue to progress towards the markets.... ► Artikel lesen | |
12.06. | Nanoform Finland Oyj: Nanoform starts Pivotal Human Bioequivalence Studies of Nanoenzalutamide | 894 | GlobeNewswire (Europe) | Nanoform Finland Plc | Press Release | June 12, 2025 at 08:10:00 EEST
HELSINKI, FINLAND, June 12, 2025 - Nanoform Finland Plc, the medicine performance-enhancing company, today announced that it had... ► Artikel lesen | |
NANOFORM FINLAND Aktie jetzt für 0€ handeln | |||||
20.05. | Nanoform Finland Oyj: Nanoform Q1 2025 report: Deal mosaic emerge and commercial value clearly seen in our CESS technology | 1.122 | GlobeNewswire (Europe) | Nanoform Finland Plc | Company Release | May 20, 2025 at 08:10:00 EEST
Term sheets agreed for several key markets around nanoenzalutamide1). First term sheet also signed around nanoencorafenib2). Negotiations... ► Artikel lesen | |
15.04. | Nanoform Finland Oyj: Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc | 827 | GlobeNewswire (Europe) | Company release
Nanoform Finland Plc
April 15, 2025
14.10 Finnish time / 13.10 Swedish time
Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc
Nanoform Finland... ► Artikel lesen | |
27.02. | Nanoform Finland Oyj: Nanoform 2024 report: Deal discussions around product kernels intensify | 1.412 | GlobeNewswire (Europe) | Company Announcement
Nanoform Finland Plc
February 27, 2025
08:10 a.m. Finnish time / 07:10 a.m. Swedish time
Nanoform 2024 report: Deal discussions around product kernels intensify
After a strong... ► Artikel lesen | |
18.11.24 | Nanoform Finland Oyj: Nanoform Q3 2024 report: Record number of new projects signed | 1.224 | GlobeNewswire (Europe) | Company Announcement
Nanoform Finland Plc
November 18, 2024
08:10 a.m. Finnish time / 07:10 a.m. Swedish time
Nanoform Q3 2024 report: Record number of new projects signed
A record number of new... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 23,450 | -3,50 % | EQS-AFR: Formycon AG: Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und Quartals-/Zwischenmitteilungen | EQS Vorabbekanntmachung Finanzberichte: Formycon AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Formycon AG: Vorabbekanntmachung über die Veröffentlichung... ► Artikel lesen | |
KOPIN | 3,266 | +11,24 % | Kopin secures $3.2M in new program orders for MicroLED displays in combat aircraft HUD upgrade | ||
GOMSPACE | 1,166 | -1,35 % | GOMSPACE GROUP AB: GomSpace Awarded EUR 760,000 ESA Contract to Advance Satellite Software Innovation | ||
DOTZ NANO | 0,035 | +1,47 % | DOTZ NANO LIMITED: Notification regarding unquoted securities - DTZ | ||
SOLESENCE | 3,440 | 0,00 % | Solésence, Inc.: Solésence Reports Second Quarter 2025 Financial Results | ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced... ► Artikel lesen | |
VEECO INSTRUMENTS | 24,400 | -1,61 % | Veeco Instruments stock downgraded by Northland on valuation concerns | ||
GAUZY | 6,920 | +0,29 % | Gauzy Ltd. Announces Second Quarter 2025 Results | Record Backlog Purchase Orders of $42.9 Million at Quarter End Highly Anticipated New Product Lines Announced; Includes Commercial Aircraft Cabin Shading, ADAS Smart Vision for Buses, and Pre-Fabricated... ► Artikel lesen | |
LAMPETIA | 0,115 | +25,00 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
ONTO INNOVATION | 110,00 | -1,79 % | Stifel hebt Kursziel für Onto Innovation auf 120 US-Dollar an | ||
ZENTEK | 0,645 | +0,78 % | Zentek Ltd.: Zentek Subsidiary Albany Graphite Corp. Provides Additional Positive Nuclear Suitability Testing Results | GUELPH, ON / ACCESS Newswire / October 6, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company, is pleased... ► Artikel lesen | |
FENDX TECHNOLOGIES | 0,550 | -6,78 % | FendX Technologies Inc.: FendX Advances Medical Catheter Coating Innovation: Provisional Patent Filed | Vancouver, British Columbia--(Newsfile Corp. - August 26, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTD) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company... ► Artikel lesen | |
OBDUCAT | 0,022 | 0,00 % | NGM MARKET NOTICE: #25-43 Information regarding the last day of trading in paid subscribed shares issued by Obducat AB | ||
ACACIA RESEARCH | 2,820 | -0,70 % | Acacia Research und Partner entwickeln eine mit Bitcoin gesicherte Gewerbedarlehensstrategie | ||
ADVANCE ZINCTEK | 0,530 | 0,00 % | ADVANCE ZINCTEK LIMITED: Improvement of 26.83% in First Quarter Revenue - FY26 | ||
NANOFOCUS | 1,760 | 0,00 % | Nanofocus: Abfindungsangebot klar über aktuellem Kurs | Seit Ende Mai ist bekannt, dass die Carl Mahr Holding Nanofocus übernehmen will. Jetzt wird die Sache sehr konkret. Die Gesellschaft aus Göttingen legt ein konkretisiertes Squeeze-Out-Verlangen vor.... ► Artikel lesen |